How many stem-cell trials for Diabetes (Type 1 & 2) are recruiting right now?
Right now 4 of 65 records (6%) carry recruiting status; the rest are completed, finished enrolling or stopped. Snapshot 2026-08-29.
Who these studies will actually take
Immune-intervention trials often require enrolment within months of diagnosis with residual C-peptide, which excludes long-standing patients. Islet-replacement studies require immunosuppression tolerance and specialist transplant follow-up, so eligibility is narrow and site-bound.
The studies currently enrolling
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT06951074 — Insulin Producing Stem Cell Transplantation Clinical Trial in Type 1 Diabetes | Phase 2, Phase 3 | Recruiting | 20 | Ain Shams University | 2025-04-01 |
| NCT06065852 — National Registry of Rare Kidney Diseases | n/a | Recruiting | 35,000 | UK Kidney Association | 2009-11-06 |
| NCT05610865 — Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers | Phase 1 | Recruiting | 28 | University of the Punjab | 2020-11-20 |
| NCT03835312 — Sequential Transplantation of UCBSCs and Islet Cells in Children and Adolescents With Monogenic Immunodeficiency T1DM | n/a | Recruiting | 50 | Children's Hospital of Fudan University | 2019-02-20 |
What recruiting does and does not mean
The status field tracks paperwork, not promise. What matters underneath it is the eligibility list, the outcome measures the sponsor committed to, and whether a site near you is actually enrolling, all of which sit on the registry record itself.
Sites sit in 23 countries, led by United States. Travelling for a trial rarely works unless the site has confirmed in writing that it can enrol non-residents and fund the follow-up schedule.
Who is running the studies here
Lead sponsors appearing most often for this condition. Useful for one specific check: whether the entity quoting research at you appears anywhere in it.
- Throne Biotechnologies Inc. — 4 registered records
- Uppsala University Hospital — 2 registered records
- Baylor Research Institute — 2 registered records
- Fuzhou General Hospital — 2 registered records
- University of Alberta — 2 registered records
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School — 2 registered records
Frequently asked
How many stem-cell trials for Diabetes (Type 1 & 2) are recruiting right now?
4 of 65 registered records (2026-08-29).
Can I join one of these trials?
Possibly, if the criteria fit and a site can take you. Nobody can promise a place on your behalf, and any intermediary charging a fee to arrange one is not part of the trial.
Do trials charge participants?
Trial participation is normally free of charge for the intervention under study; some studies even reimburse travel. Payment demands invert that relationship and should stop the conversation.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
More on this condition
- Diabetes (Type 1 & 2): cell-therapy evidence and registered trials
- How much does stem cell therapy for Diabetes (Type 1 & 2) cost? (2026)
- Diabetes (Type 1 & 2) stem cell therapy — your questions answered (2026)
- Diabetes (Type 1 & 2): cell-therapy evidence by therapy class
- MSC vs HSCT for Diabetes (Type 1 & 2): what the registries show